Global Health’s shares rose by over 2% following the release of its Q2 FY25 financial results, which showed a significant growth in both revenue and net profit compared to the same period last year.
The company reported a net profit of ₹130.8 crore, marking a 4.5% increase from ₹125.2 crore in Q2 FY24. Revenue also saw a strong rise, reaching ₹956.5 crore, up 12.5% from ₹850.4 crore in the previous year. EBITDA grew by 4%, standing at ₹228.2 crore, compared to ₹219.4 crore in Q2 FY24.
However, despite the positive financial results, the EBITDA margin experienced a slight decline to 23.9%, down from 25.8% in the same quarter last year. This was attributed to higher operational costs and ongoing investments.
As of 1:59 pm, Global Health shares were trading 2.56% higher at Rs 1,059.00 on the NSE.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
